Phocaeicola vulgatus mitigates obesity via the arginine-retinoic acid axis, providing a valuable scientific basis for exploring this strain as a probiotic candidate for metabolic health.
Key Findings
Results
The P. vulgatus-centered microbial network and ornithine synthesis are impaired in obese individuals compared to lean individuals.
An independent clinical cohort comprising obese and lean individuals was established to characterize microbiome differences.
P. vulgatus-centered network connectivity was reduced in the obese group.
Ornithine synthesis, a precursor pathway to arginine biosynthesis, was specifically identified as impaired in obesity.
This finding was derived from clinical cohort analysis prior to any intervention.
Results
P. vulgatus supplementation significantly mitigates high-fat diet (HFD)-induced obesity in a humanized rat model.
A humanized rat model was established using microbiota transplanted from a P. vulgatus-deficient obese patient.
P. vulgatus supplementation led to significant reductions in body weight.
Serum total cholesterol levels were reduced following P. vulgatus supplementation.
Hepatic steatosis was alleviated by P. vulgatus supplementation.
The model was used to confirm causality between P. vulgatus abundance and metabolic outcomes.
Results
P. vulgatus engages in a cross-species functional association with Phascolarctobacterium faecium that enhances intestinal arginine biosynthesis and systemic arginine availability.
Integrated metagenomic and metabolomic analyses were used to identify the functional association.
The interaction between P. vulgatus and P. faecium was identified as a key driver of intestinal arginine production.
This cross-species interaction resulted in elevated circulating arginine levels in the host.
The finding represents a microbial cooperative mechanism underlying the metabolic benefits of P. vulgatus.
Results
Elevated circulating arginine levels resulting from P. vulgatus activity are linked to upregulation of hepatic retinoic acid (RA) signaling.
Hepatic transcriptomics was used to connect systemic arginine availability to downstream hepatic gene expression.
Retinoic acid signaling pathways were upregulated in association with higher circulating arginine.
This arginine-RA axis represents the proposed mechanistic link between gut microbiota activity and hepatic metabolic improvement.
The authors describe this as a 'potential microbial-host network' connecting P. vulgatus to host metabolism.
Background
FMT shows inconsistent clinical efficacy in treating obesity, and specific microbial determinants of its success were previously poorly characterized.
A previous clinical FMT trial by the same group identified P. vulgatus as a key microbe contributing to therapeutic efficacy.
The current study was designed to further characterize the mechanisms underlying P. vulgatus-mediated benefits.
The inconsistency of FMT efficacy motivated investigation into specific bacterial contributors.
P. vulgatus is proposed as a probiotic candidate for metabolic health based on these findings.
What This Means
This research suggests that a specific gut bacterium called Phocaeicola vulgatus plays an important role in preventing obesity. The researchers found that obese people have less of this bacterium and a disrupted network of related microbes compared to lean individuals. When they transplanted gut bacteria from an obese person lacking P. vulgatus into rats and then gave those rats P. vulgatus as a supplement, the rats gained less weight, had lower cholesterol, and showed less fat buildup in their livers even while eating a high-fat diet.
The study also uncovered how P. vulgatus produces these benefits. The bacterium works together with another gut microbe, Phascolarctobacterium faecium, to produce more of the amino acid arginine in the intestine. This extra arginine enters the bloodstream and travels to the liver, where it activates a signaling pathway involving retinoic acid (a derivative of vitamin A) that appears to improve metabolic health.
This research suggests that P. vulgatus could potentially be developed as a probiotic to help treat or prevent obesity by improving the gut microbiome's ability to produce arginine and activate beneficial liver pathways. It also helps explain why fecal microbiota transplantation — a treatment where gut bacteria from healthy donors are transferred to patients — works inconsistently for obesity, as the presence or absence of specific bacteria like P. vulgatus may be critical to its success.
Li Y, Li J, Deng J, Xia P, Zhou G, Zhu Z, et al.. (2026). Phocaeicola vulgatus alleviates obesity through cross-species arginine production and hepatic retinoic acid signaling.. Food research international (Ottawa, Ont.). https://doi.org/10.1016/j.foodres.2026.120365